Abstract
The discovery that vascular endothelial cells can synthesize autocrine and paracrine substances that can alter the tone of the underlying smooth muscle and inhibit the aggregation of platelets revealed novel mechanisms that may contribute to cardiovascular homeostasis. This began with a series of studies that led to the discovery of prostacyclin41 and was followed by the demonstration that endothelial cells also form a nonprostanoid substance that was termed “endothelium-derived relaxing factor” (EDRF).21 Subsequent studies have shown that the major EDRF is nitric oxide or a labile nitroso compound20,27 formed from L-arginine in the endothelial ce11.42
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Badr, K., J. Murray, M. Breyer, K. Takahashi, T. Inagami, and R. Harris. Mesangial cell, glomerular, and renal vascular responses to endothelin in the rat kidney. J. Clin. Invest. 83: 336–342, 1989.
Boarder, M. R., and D. B. Marriott. Characterization of endothelin-1 stimulation of catecholamine release from adrenal chromaffin cells. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S223–S224, 1989.
Boulanger, C., and T. F. L Uscher. Release of endothelin from the porcine aorta—inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85: 587–590, 1990.
Bonhomme, M. C., M. Cantin, and R. Garcia. Relaxing effect of atrial natriuretic factor on endothelin-precontracted strips. Proc. Soc. Exp. Biol. Med. 191: 309–315, 1989.
Brown, A. M. Receptors under pressure: an update on baroreceptors. Circ. Res. 46: 1–10, 1980.
Chapleau, M. W., G. Hajduczok and F. M. Abboud. Mechanisms of resetting of arterial baroreceptors: an overview. Am. J. Med. Sci. 295 (4): 327–334, 1988.
Chapleau, M. W., G. Hajduczok, and F. M. Abboud. Endothelin suppresses baroreceptor activity: a new mechanism contributing to hypertension?, abstracted. Hypertension 14 (3): 336, 1989.
Clozel, M., and W. FiscHli Human cultured endothelial cells do secrete endothelin-1 J. Cardiovasc. Pharmacol. 13 (Suppl. 5): 5229–5231, 1989.
Cocks, T. M., S. J. King, R. A. Woods, and J. A. Angus. Hemoglobin increases the amount of endothelin present in conditioned media of cultured endothelial cells. Proc. Aust. Physiol. Pharmacol. Soc. 20: 115, 1989.
Cozza, E. N., C. E. Gomezsanchez, M. F. Foecking, and S. Chiou. Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion. J. Clin. Invest. 84: 1032–1035, 1989.
Davenport, A. P., D. J. Nunez, J. A. Hall, A. J. Kaumann, and M. J. Brown. Autoradiographical localization of binding sites for porcine [125]endothelin-1 in humans, pigs, and rats: functional relevance in humans. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S166–S170, 1989.
Demey, J. G., M. Claeys, and P. M. Vanhoutte. Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery. J. Pharmacol. Exp. Ther. 222: 166–173, 1983.
Demey, J. G., and P. M. Vanhoutte. Heterogenous behavior of the canine arterial and venous wall. Circ. Res. 51: 439–447, 1982.
DE Nucci, G. R., R. Thomas, P. D’OrlËAns-Juste, E. Antunes, T. D. Walder, and J. R. Vane. Pressor effects of circulatory endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. Usa 85: 9797–9800, 1988.
Dubin, D., R. E. Pratt, J. P. Cooke, and V. J. DzAU. Endothelin, a potent vasoconstrictor, is a vascular smooth-muscle mitogen, abstracted. Clin. Res. 37: 517, 1989.
Dzau, V. J., and G. H. Gibbons. Cell biology of vascular hypertension in systemic hypertension. Am. J. Cardiol. 62: 30G - 35G, 1988.
Emori, T., Y. Hirata, K. Ohta, M. Shichirn, and F. Marumo. Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. Biochem. Biophys. Res. Commun. 160: 93–100, 1989.
Ferrario, R. G., R. FouLkes, P. Salvati, C. Patrons. Hemodynamic and tubular effects of endothelin and thromboxane in the isolated perfused rat kidney. Eur. J. Pharmacol. 171: 127–134, 1989.
Fukuda, Y., Y. Hirata, H. Yshimi, T. Kojima, Y. Kobayashi, M. Yanagisawa, and T. Masaki. Endothelin is a potent secretagogue for atrial natriuretic peptide cultured in rat atrial myocytes. Biochem. Biophys. Res. Commun. 155 (1): 167–172, 1988.
Furchgott, R. F., M. T. Khan, and D. Jothianandan. Comparison of endothelium dependent relaxation and nitric oxide induced relaxation in rabbit aorta, abstracted. Federation Proc. 46: 385, 1987.
Furchgott, R. F., and J. V. Zawadzki. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376, 1980.
Goetz, K. L., B. C. Wang, J. B. Madwed, J. L. Zhu, R. J. Leadley, JR. Cardiovascular, renal and endocrine responses to intravenous endothelin in conscious dogs. Am. J. Physiol. 255 (Regulatory Integrative Comp. Physiol. 24 ): R1064 - R1068, 1988.
Harder, D. R. Pressure-induced myogenic activation of cat cerebral arteries is dependent on intact endothelim. Circ. Res. 60: 102–107, 1987.
Heesch, C. M., F. M. Abboud, and M. D. Thames. Acute resetting of carotid sinus baro-receptors. II. Possible involvement of electrogenic Na pump. Am. J. Physiol. 247: (Heart Circ. Physiol. 16 ): H833 - H834, 1984.
Hickey, K. A., G. Rubanyi, R. J. Paul, and R. F. Highsmith. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am. J. Physiol. 248 (Cell Physiol. 17): C550–0556, 1985.
Hu, R. J., U. G. Berninger, and R. E. Lang. Endothelin stimulates atrial natriuretic peptide (Anp) release from rat atria. Eur. J. Pharmacol. 158: 177–178, 1988.
Ignarro, L. J., R. Byrns, and K. S. Wood. Pharmacological and biochemical properties of Edrf: evidence that Edrf is closely related to nitric oxide radical, abstracted. Circ. Res. 74 (Suppl. II): II - 287, 1986.
Katusic, Z. S., J. T. Shepherd, and P. M. Vanhoutte. Endothelium-dependent contractions to stretch in canine basilar arteries, abstracted. Federation Proc. 45: 289, 1986.
Kawaguchi, H., K. Ito, and H. Yasuda. Endothelin stimulates angiotensin converting enzyme activity. Presented at The International Society of Hypertension, 13th Scientific Meeting, Montreal, December 1990.
Khayutin, V. M., A. M. Melkumyants, A. N. RoGoza, E. S. Veselova, S. A. Balashov, and V. P. Nikolsky. Flow-induced control of arterial lumen, abstracted. Acta Physiol. Hung. 68: 334, 1989.
King, A. J., B. M. Brenner, and S. Anderson Endothelin: a potent renal and systemic vasoconstrictor peptide. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25 ): F1051 - F1058, 1989.
King, A. J., J. M. Pfeffer, M. A. Pfeffer, and B. M. Brenner. Systemic hemodynamic effects of endothelin in the rat. Am. J. Physiol. 258: (Heart Circ. Physiol. 27 ): H787 - H792, 1990.
Knuepfer, M.M., S. P. Han, A. J. Trapani, K. F. Fox, and T. C. Westfall. Regional hemodynamic and baroreflex effects of endothelin in rats. Am. J. Physiol. 257 (Heart Circ. Physiol. 26 ): H918 - H926, 1989.
Kohzuki, M., C. I. Johnston, S. Y. Chai, D. J. Casley, F. Rogerson, and F. A. O. Mendelsohn. Endothelin receptors in rat adrenal gland visualized by quantitative autoradiography. Clin. Exp. Pharmacol. Physiol. 14 (4): 239–242, 1989.
Koseki, C., M. Imai, Y. Hirata, M. Yanagisawa, and T. Masaki. Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide ? Am. J. Physiol. (Regulatory Integrative Comp. Physiol. 25 ): R858 - R866, 1989.
Langille, B. L., and F. O’Donnell. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 231: 405–407, 1986.
Lopezfarre, A., I. Montanes, I. Millas, and J. Lopeznovoa. Effect of endothelin on renal function in rats. Eur. J. Pharmacol. 163: 187–189, 1989.
Matsumura, Y., K. Nakase, R. Ikegawa, K. Hayashi, T. Ohyama, and S. Morimoto. The endothelin-derived vasoconstrictor peptide endothelin inhibits renin release in vitro. Life Sci. 44 (2): 149–157, 1989.
Mcdowell, T. S., T. S. Axtelle, M. W. Chapleau, and F. M. Abboud. Prostaglandins in carotid sinus enhance baroreflex in rabbits. Am. J. Physiol. 257 (Regulatory Integrative Comp. Physiol. 26 ): R445 - R450, 1989.
Miller, W. L., M. M. Redfield, and J. C. Burnett, JR. Integrated cardiac, renal, and endocrine actions of endothelin. J. Clin. Invest. 83: 317–320, 1989.
Moncada, S., R. Gryglewski, S. Bunting, and J. R. Vane. An enzyme isolated from arteries transforms prostaglandin endoperoxidase to an unstable substance that inhibits platelet aggregation. Nature 263: 663–665, 1976.
Morishita, R., J. Higaki, and T. Ogihara. Endothelin stimulates aldosterone biosynthesis by dispersed rabbit adreno-capsular cells. Biochem. Biophys. Res. Commun. 160 (2): 628–632, 1989.
Palmer, R. M. J., A. G. Ferrige, and S. Moncada. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524–526, 1987.
Rakugi, H., M. Nakamaru, H. Saito, J. Higaki, and T. Ogigara. Endothelin inhibits renin release from isolated rat glomeruli. Biochem. Biophys. Res. Commun. 155(3): 12441247, 1988.
Rubanyi, G. M. Endothelium-dependent pressure-induced contraction of isolated canine carotid arteries. Am. J. Physiol. 255 (Heart Circ. Physiol. 24 ): H783 - H788, 1988.
Rubanyi, G. M. Endothelium-derived vasoconstrictor factors. In: Endothelial Cell, edited by U. S. Ryan. Cleveland, OH: Crc, 1985, vol. Iii, p. 61–74.
Rubanyi, G. M. Maintenance of “basal” vascular tone may represent a physiological role for endothelin. J. Vase. Med. Biol. 6: 315–316, 1989.
Rubanyi, G. M., C. J. Romero and P. M. Vanhoutte. Flow-induced release of endothelium-derived relaxing factor. Am. J. Physiol. 250 (Heart Circ. Physiol. 19 ): H1145 - H1149, 1986.
Rubanyi, G. M., and P. M. Vanhoutte. Hypoxia releases a vasoconstrictor substance from canine vascular endothelium. J. Physiol. 364: 45–56, 1985.
Schini, V. B., H. Hendrickson, D. M. Heublein, J. C. Burnett, JR., and P. M. Vanhoutte. Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur. J. Pharmacol. 165: 333–334, 1989.
Stasch, J. P., C. Hirth-Dietrich, S. Kazda, D. Neuser. Endothelin stimulates release of natriuretic peptides in vitro and in vivo. Life Sci. 45 (10): 869–875, 1989.
Tabuchi, Y., M. Nakamuru, H. Rakugi, M. Nagano, H. Mikami, and T. Ogihara. Endothelin interacts with the neuroeffector junction in rat mesenteric artery, abstracted. Hypertension 14 (3): 336, 1989.
Takagi, M., H. Matsuoka, K. Atarashi, and S. Yagi. Endothelin: a new inhibitor of renin release. Biochem. Biophys. Res. Commun. 157 (3): 1164–1168, 1988.
Takashi, H., M. Nishimura, M. Matsusawa, I. Ikegaki, M. Sakamoto, and M. Yoshimura. Centrally-induced cardiovascular effects. of endothelin in conscious rats. Presented at The International Society of Hypertension, 13th Scientific Meeting, Montreal, December 1990.
Tesfamariam, B., and R. A. Cohen. Inhibition of adrenergic vasoconstriction by endothelial cell shear stress. Circ. Res. 63: 720–725, 1988.
Thiemermann, C., P. S. Lidbury, G. R. Thomas, and J. R. Vane. Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S138 - S141, 1989.
Vanhoutte, P. M., W. Auch-Schwelk, and C. Boulanger. Does endothelin-1 mediate endothelium-dependent contractions during anoxia? J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S124 - S128, 1989.
Winquist, R. J., A. L. Scott, and G. P. Vlasuk. Enhanced release of atrial natriuretic factor by endothelin in atria from hypertensive rats. Hypertension 14 (1): 111–114, 1989.
Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kabayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415, 1988.
Yashizawa T, O. Shinmi, A. Giaid, M. Yanagisawa, J. Gibson, S. Kimura, Y. Ochiyama, J. M. Polak, T. Masaki, and I. Kanazawa. Endothelin is a novel peptide in the posterior pituitary system. Science 247: 462–464, 1990.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 American Physiological Society
About this chapter
Cite this chapter
Rubanyi, G.M., Shepherd, J.T. (1992). Hypothetical Role of Endothelin in the Control of the Cardiovascular System. In: Rubanyi, G.M. (eds) Endothelin. Clinical Physiology Series. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7514-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7514-9_16
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-7514-9
eBook Packages: Springer Book Archive